Black Phenyl Concentrate Manufacturing — Standard Project Report
Black Phenyl Concentrate Manufacturing in India — what the report covers
Phenyl concentrate is ready-to-use phenyl with most of the water taken out — one litre makes 20–50 litres of usable disinfectant. Because the water that adds no value is left for the buyer to add, concentrate sells for ₹105–220 per litre against ₹14–29 for ready-to-use bulk phenyl, ships across the country economically, and is the format re-packers, private-label brands and institutions prefer.
Market at a glance
India’s surface-cleaner market was USD 870.3 million in 2024, projected to USD 1,557 million by 2033 at a 6.14% CAGR (IMARC Group); surface-disinfectant products were USD 201.45 million in 2024, growing 7.12% a year (TechSci Research). There is no separately published concentrate-only market figure, so the report sizes the opportunity from those markets and from concentrate price and demand signals — the concentrate share of phenyl volume has been rising structurally as freight costs climb and institutional buyers move to in-house dilution.
Manufacturing process
A batch blending operation with no hazardous reaction step — the only technically demanding part is standardisation, adjusting each batch so that at the labelled dilution it hits the target germicidal (Rideal-Walker) coefficient for its grade.
Key statutory point
BIS licence (ISI mark to IS 1061:2017) is not universally mandatory today but is effectively required for hospital, railway, defence, PSU and government supply — with testing done at the labelled dilution. A Quality Control Order review covering IS 1061 is under way.
3 independently costed setups
| Configuration | Total funds | Capacity | Operating model |
|---|---|---|---|
| Low-Investment Unit | ₹21.5 lakh | 1,20,000 L/yr | Manual, rented shed, unbranded bulk concentrate |
| Standard Small-Scale Unitanchor | ₹1.13 crore | 5,40,000 L/yr | Semi-automatic, rented unit, branded + institutional + private-label |
| Expanded / Semi-Automated Unit | ₹3.24 crore | 12,00,000 L/yr | Automated, owned plant, own brand + private label + export |
Total funds required = cost of project + working capital, on a 100%-own-funds basis. Each configuration is costed bottom-up from a researched equipment list, premises basis and manpower roster — not scaled from one another. The report is funding-neutral: it makes no assumption about how the promoter raises the capital.
Anchor configuration — 5-year financial model
Projected / indicative figures on the GF Standard Basis (cost basis August 2026, Tier-2 Indian industrial location, straight-line depreciation, 25% tax, no financing layer). Verify independently before committing funds.
Applicable public standards referenced: IS 1061:2017 — Disinfectant Fluids, Phenolic Type · Rideal-Walker / phenol-coefficient test methods · Drugs & Cosmetics Rules (germicidal claim labelling).
Every section, in order
- Product description, applications and end-use segments
- Market analysis with cited third-party sources
- Manufacturing process at unit-operation level, with a process-flow diagram
- 1–3 independently costed investment configurations (low-investment → standard → expanded)
- Plant & machinery lists with indicative August-2026 costs
- Raw materials by functional class, with cost split and availability
- Infrastructure, utilities and manpower
- Full statutory & environmental compliance roadmap (Udyam, GST, Factory licence, PCB, Fire NOC, BIS, product-specific licences)
- 5-year financial model for the anchor configuration — cost of project, working capital, projected P&L, break-even, IRR / NPV / payback
- Low-investment trade-off disclosure with a viability verdict
- SWOT analysis
- Annexures — standards & references, sector bodies & testing labs, glossary
What this report does not include
- Manufacturing formulations, recipes or batch sheets
- Raw-material specifications, grades or brand names
- Supplier or vendor lists
- Technical, engineering or QC consulting
This is a business feasibility study, not a technical manual. For production-ready formulations, raw-material profiles and QC targets, see the matching Formulations Handbook.
Built for the person doing the planning
First-time entrepreneurs
A realistic, bottom-up view of what it costs to start — and the lowest-investment setup that still works and is legal.
Existing manufacturers
Adding a new product line and needing to size the capex, working capital and returns before committing.
Proposal preparation
A structured, sourced starting point for a project proposal or an internal investment case.
Consultants & students
A worked example of an MSME feasibility study for a formulated-chemical product.
Frequently asked questions
Why make phenyl concentrate instead of ready-to-use phenyl?
Concentrate has most of the water removed, so it sells at ₹105–220/L against ₹14–29/L for ready-to-use bulk, ships economically nationwide, and is the format re-packers, private-label brands and institutions prefer. The trade-off is that it needs precise batch standardisation to the target germicidal coefficient.
What returns does the concentrate business model show?
The anchor shows a ~32% project IRR and a ~3.3-year payback — a genuinely strong margin because the buyer pays for disinfecting power, not water and freight. The report is explicit that this is not a modelling artefact, but it assumes the unit can place ~5.4 lakh litres a year of a competitively priced branded and institutional product, which takes real distribution effort.
Why is working capital about three times the cost of the plant?
The plant is cheap — a blending operation — but concentrate carries expensive terpene / phenolic actives inventory (70–85% of raw-material cost) and the institutional trade pays slowly. In the anchor, working capital (₹83.78 lakh) is roughly three times the cost of the project (₹28.82 lakh), and the report flags this as the defining planning point.
How is this report different from the ready-to-use phenyl report?
Different product, different economics. Ready-to-use phenyl is a dense, low-value, short-freight-radius product; concentrate is high-value, ships nationwide and can export. This report models concentrate-specific machinery, the standardisation step as the technical core, the working-capital intensity, and an export-capable expanded configuration.
Will this report give me the formulation?
No. Standard Project Reports are feasibility and financial studies only. Raw materials are described by functional class (e.g. "anionic surfactant"), never by grade, trade name or supplier. For production-ready formulations, see the matching Global Formulation handbook.
How are the investment figures arrived at?
Each configuration is costed bottom-up from researched equipment, premises and manpower — not scaled from a single template. The report presents the total funds required (cost of project + working capital) on a 100%-own-funds basis; it does not assume or advise on how you raise the capital.
What format is it and how do I get it?
A PDF, delivered by instant download link the moment payment is confirmed, and kept in your library. Up to 5 downloads are included.
How current are the costs?
The cost basis is August 2026, benchmarked to a Tier-2 Indian industrial location against public marketplace listings and MSME project profiles. All figures are indicative and must be verified with vendors and professionals before you commit funds.
This report is a detailed answer to searches such as: phenyl concentrate manufacturing plant cost · phenyl concentrate making business project report · black phenyl concentrate manufacturing process · phenyl concentrate vs ready to use business · phenyl concentrate machinery list.
